US FDA to exempt certain IVDs, radiology devices from 510(k) review
This article was originally published in Clinica
Executive Summary
The US FDA has announced plans to ease the pre-market notification, or 510(k), requirements for certain in vitro diagnostics and radiology devices with well established safety and effectiveness profiles.